Skip to main content

QELBREE

Generic: viloxazine hydrochloride

Verified·Oct 26, 2026
Manufacturer
Supernus
NDC
17772-131
RxCUI
2536548
Route
ORAL
ICD-10 indication
F90.9

Affordability Check

How much will you actually pay for QELBREE?

In 30 seconds, see every legitimate way to afford QELBREE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About QELBREE

What is this medication? Qelbree is a prescription medication used for the treatment of attention-deficit hyperactivity disorder, commonly known as ADHD. It is approved for use in both children aged six and older as well as in adults. Unlike many other common treatments for this condition, Qelbree is a non-stimulant medication. It belongs to a class of drugs called selective norepinephrine reuptake inhibitors, which work by increasing the levels of certain natural substances in the brain that help manage focus and impulse control.

This medication is typically taken once daily in the form of an extended-release capsule. Because it is not a controlled substance, it does not carry the same potential for abuse or dependence as many stimulant-based ADHD treatments. Healthcare providers often prescribe it to help patients reduce symptoms such as hyperactivity, distractibility, and impulsiveness. It is important for patients and caregivers to monitor for any changes in mood or behavior while using this drug, as is standard with many medications that affect the central nervous system.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Offer is available to most commercially insured and cash-paying patients; not valid for patients enrolled in Medicaid, Medicare, or any other federal or state healthcare program (including medical assistance programs); valid only for Qelbree prescriptions in the United States and Puerto Rico; not valid where prohibited by law; cannot be combined with any other offer.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How QELBREE appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

0%

16 of 5,499 plans

Most common tier

Tier 4

On 67% of covering formularies

Prior authorization required

33%

of covering formularies

TierFormularies on this tierShare
Tier 2 (generic)1
33%
Tier 4 (non-preferred brand)2
67%

Step therapy: 67% of formularies

Quantity limits: 100% of formularies

Coverage breadth: 3 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.